{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T10:44:33Z","timestamp":1747737873413,"version":"3.37.3"},"reference-count":39,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,6]],"date-time":"2024-05-06T00:00:00Z","timestamp":1714953600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82222059","81930087","82173416"],"award-info":[{"award-number":["82222059","81930087","82173416"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Analysis"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.jpha.2024.100998","type":"journal-article","created":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T02:17:38Z","timestamp":1715221058000},"page":"100998","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Circulating memory T cells and TCF1+ T cells aid in diagnosis and monitor disease activity in vitiligo"],"prefix":"10.1016","volume":"14","author":[{"given":"Xinju","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianru","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-8310-576X","authenticated-orcid":false,"given":"Wei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinrong","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7360-0117","authenticated-orcid":false,"given":"Luling","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiwei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaiqiao","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuli","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunying","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpha.2024.100998_bib1","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0140-6736(14)60763-7","article-title":"Vitiligo","volume":"386","author":"Ezzedine","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.jpha.2024.100998_bib2","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jaad.2009.03.022","article-title":"The burden of vitiligo: Patient characteristics associated with quality of life","volume":"61","author":"Linthorst Homan","year":"2009","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.jpha.2024.100998_bib3","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s12016-017-8622-7","article-title":"Vitiligo: Focus on clinical aspects, immunopathogenesis, and therapy","volume":"54","author":"Boniface","year":"2018","journal-title":"Clin. Rev. Allergy. Immunol."},{"key":"10.1016\/j.jpha.2024.100998_bib4","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1038\/jid.2014.527","article-title":"Maintenance therapy of adult vitiligo with 0.1% tacrolimus ointment: A randomized, double blind, placebo-controlled study","volume":"135","author":"Cavali\u00e9","year":"2015","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jpha.2024.100998_bib5","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.jid.2018.10.032","article-title":"Resident memory and recirculating memory T cells cooperate to maintain disease in a mouse model of vitiligo","volume":"139","author":"Richmond","year":"2019","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jpha.2024.100998_bib6","doi-asserted-by":"crossref","first-page":"11","DOI":"10.4049\/jimmunol.1900027","article-title":"The Role of Memory CD8+ T Cells in Vitiligo","volume":"203","author":"Riding","year":"2019","journal-title":"J. Immunol."},{"key":"10.1016\/j.jpha.2024.100998_bib7","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.jid.2017.08.038","article-title":"Vitiligo skin is imprinted with resident memory CD8 T cells expressing CXCR3","volume":"138","author":"Boniface","year":"2018","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jpha.2024.100998_bib8","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1111\/bjd.18902","article-title":"Phenotype and function of circulating memory T cells in human vitiligo","volume":"183","author":"Martins","year":"2020","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.jpha.2024.100998_bib9","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/s41577-021-00563-6","article-title":"TCF1 in T cell immunity: A broadened frontier","volume":"22","author":"Zhao","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jpha.2024.100998_bib10","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.immuni.2018.12.021","article-title":"Intratumoral Tcf1+PD-1+CD8+ T cells with stem-like properties promote tumor control in response to vaccination and checkpoint blockade immunotherapy","volume":"50","author":"Siddiqui","year":"2019","journal-title":"Immunity."},{"key":"10.1016\/j.jpha.2024.100998_bib11","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/s41590-019-0312-6","article-title":"Subsets of exhausted CD8+ T cells differentially mediate tumor control and respond to checkpoint blockade","volume":"20","author":"Miller","year":"2019","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jpha.2024.100998_bib12","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.136648","article-title":"TCF-1 regulates HIV-specific CD8+ T cell expansion capacity","volume":"6","author":"Rutishauser","year":"2021","journal-title":"JCI Insight"},{"key":"10.1016\/j.jpha.2024.100998_bib13","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1158\/2326-6066.CIR-22-0524","article-title":"Self-renewing CD8+ T-cell abundance in blood associates with response to immunotherapy","volume":"11","author":"Maniar","year":"2023","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.jpha.2024.100998_bib14","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.immuni.2018.08.002","article-title":"CD8+ T cell priming in established chronic viral infection preferentially directs differentiation of memory-like cells for sustained immunity","volume":"49","author":"Snell","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.jpha.2024.100998_bib15","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/s41586-021-04248-x","article-title":"An autoimmune stem-like CD8 T cell population drives type 1 diabetes","volume":"602","author":"Gearty","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.jpha.2024.100998_bib16","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/JD9.0000000000000151","article-title":"Consensus on the diagnosis and treatment of vitiligo in china (2021 Revision)","volume":"4","author":"Lei","year":"2021","journal-title":"Int. J. Dermatol. Venereol."},{"key":"10.1016\/j.jpha.2024.100998_bib17","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1001\/archderm.1997.03890430144030","article-title":"Comparison of computer-aided design and rule of nines methods in the evaluation of the extent of body involvement in cutaneous lesions","volume":"133","author":"Kanthraj","year":"1997","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.jpha.2024.100998_bib18","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/44385","article-title":"Two subsets of memory T lymphocytes with distinct homing potentials and effector functions","volume":"401","author":"Sallusto","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.jpha.2024.100998_bib19","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/imr.12762","article-title":"T-cell positioning by chemokines in autoimmune skin diseases","volume":"289","author":"Richmond","year":"2019","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.jpha.2024.100998_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2021.102868","article-title":"Emerging role of tissue resident memory T cells in vitiligo: From pathogenesis to therapeutics","volume":"20","author":"Shah","year":"2021","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jpha.2024.100998_bib21","doi-asserted-by":"crossref","DOI":"10.1111\/exd.14982","article-title":"Compromised melanocyte survival due to decreased suppression of CD4+ & CD8+ resident memory T cells by impaired TRM-regulatory T cells in generalized vitiligo patients","volume":"33","author":"Shah","year":"2024","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.jpha.2024.100998_bib22","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1016\/j.jaci.2018.11.031","article-title":"Blood endotyping distinguishes the profile of vitiligo from that of other inflammatory and autoimmune skin diseases","volume":"143","author":"Czarnowicki","year":"2019","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.jpha.2024.100998_bib23","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1002\/cyto.a.23724","article-title":"Comprehensive phenotyping of T cells using flow cytometry","volume":"95","author":"Mousset","year":"2019","journal-title":"Cytometry A."},{"key":"10.1016\/j.jpha.2024.100998_bib24","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/ni889","article-title":"Lineage relationship and protective immunity of memory CD8 T cell subsets","volume":"4","author":"Wherry","year":"2003","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jpha.2024.100998_bib25","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.coi.2005.07.020","article-title":"T cell development and receptor diversity during aging","volume":"17","author":"Goronzy","year":"2005","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.jpha.2024.100998_bib26","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/bjd.20596","article-title":"British Association of Dermatologists guidelines for the management of people with vitiligo 2021","volume":"186","author":"Eleftheriadou","year":"2022","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.jpha.2024.100998_bib27","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1111\/jdv.18134","article-title":"Assessing the dynamic changes in vitiligo: reliability and validity of the Vitiligo Disease Activity Score (VDAS) and Vitiligo Disease Improvement Score (VDIS)","volume":"36","author":"van Geel","year":"2022","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.jpha.2024.100998_bib28","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1111\/bjd.18950","article-title":"Reliability and validity of the Vitiligo Signs of Activity Score (VSAS)","volume":"183","author":"van Geel","year":"2020","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.jpha.2024.100998_bib29","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1069196","article-title":"Circulatory levels of alarmins in patients with non-segmental vitiligo: Potential biomarkers for disease diagnosis and activity\/severity assessment","volume":"13","author":"He","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jpha.2024.100998_bib30","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.739413","article-title":"Clinical significance of serum oxidative stress markers to assess disease activity and severity in patients with non-segmental vitiligo","volume":"9","author":"Li","year":"2021","journal-title":"Front. Cell. Dev. Biol."},{"key":"10.1016\/j.jpha.2024.100998_bib31","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1001\/jamadermatol.2016.2366","article-title":"Clinical significance of serum soluble CD molecules to assess disease activity in vitiligo","volume":"152","author":"Speeckaert","year":"2016","journal-title":"JAMA Dermatol."},{"key":"10.1016\/j.jpha.2024.100998_bib32","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.jaad.2016.12.021","article-title":"Suction blistering the lesional skin of vitiligo patients reveals useful biomarkers of disease activity","volume":"76","author":"Strassner","year":"2017","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.jpha.2024.100998_bib33","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1111\/bjd.14416","article-title":"Increased expression of CXCR3 and its ligands in patients with vitiligo and CXCL10 as a potential clinical marker for vitiligo","volume":"174","author":"Wang","year":"2016","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.jpha.2024.100998_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.102885","article-title":"Reappearance of effector T cells is associated with recovery from COVID-19","volume":"57","author":"Odak","year":"2020","journal-title":"EBioMedicine"},{"key":"10.1016\/j.jpha.2024.100998_bib35","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1182\/bloodadvances.2018016279","article-title":"TCF1 expression marks self-renewing human CD8+ T cells","volume":"2","author":"Kratchmarov","year":"2018","journal-title":"Blood Adv."},{"key":"10.1016\/j.jpha.2024.100998_bib36","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.celrep.2017.04.014","article-title":"Label-free analysis of CD8+ T cell subset proteomes supports a progressive differentiation model of human-virus-specific T cells","volume":"19","author":"van Aalderen","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.jpha.2024.100998_bib37","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/j.immuni.2016.10.022","article-title":"Epigenomic profiling of human CD4+ T cells supports a linear differentiation model and highlights molecular regulators of memory development","volume":"45","author":"Durek","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.jpha.2024.100998_bib38","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1038\/jid.2009.32","article-title":"Autoimmune destruction of skin melanocytes by perilesional T cells from vitiligo patients","volume":"129","author":"van den Boorn","year":"2009","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jpha.2024.100998_bib39","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1046\/j.1523-1747.2001.01408.x","article-title":"Specific cytotoxic T lymphocyte responses against Melan-A\/MART1, tyrosinase and gp100 in vitiligo by the use of major histocompatibility complex\/peptide tetramers: The role of cellular immunity in the etiopathogenesis of vitiligo","volume":"117","author":"Palermo","year":"2001","journal-title":"J. Invest. Dermatol."}],"container-title":["Journal of Pharmaceutical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2095177924000959?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2095177924000959?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,21]],"date-time":"2024-12-21T00:08:17Z","timestamp":1734739697000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2095177924000959"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":39,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S2095177924000959"],"URL":"https:\/\/doi.org\/10.1016\/j.jpha.2024.100998","relation":{},"ISSN":["2095-1779"],"issn-type":[{"type":"print","value":"2095-1779"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Circulating memory T cells and TCF1+ T cells aid in diagnosis and monitor disease activity in vitiligo","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpha.2024.100998","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V. on behalf of Xi\u2019an Jiaotong University.","name":"copyright","label":"Copyright"}],"article-number":"100998"}}